{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:08:32Z","timestamp":1790507312018,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T00:00:00Z","timestamp":1538265600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National research foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2015R1C1A1A01054293"],"award-info":[{"award-number":["NRF-2015R1C1A1A01054293"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s10096-018-3392-6","type":"journal-article","created":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T00:26:46Z","timestamp":1538267206000},"page":"67-74","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Inoculum effect of methicillin-susceptible Staphylococcus aureus against broad-spectrum beta-lactam antibiotics"],"prefix":"10.1007","volume":"38","author":[{"name":"the Korea INfectious Diseases (KIND) study group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Ho","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sook-In","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7652-7093","authenticated-orcid":false,"given":"Shinwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eu Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Hwa","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Beom","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pyoeng Gyun","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Keun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Gyung","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Chang","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungmin","family":"Kiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-In","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Bin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,30]]},"reference":[{"issue":"23","key":"3392_CR1","first-page":"e394","volume":"111","author":"LM Baddour","year":"2005","unstructured":"Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA (2005) Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111(23):e394\u2013e434","journal-title":"Circulation"},{"issue":"5","key":"3392_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000087452","volume":"51","author":"KF Bodmann","year":"2005","unstructured":"Bodmann KF (2005) Current guidelines for the treatment of severe pneumonia and sepsis. Chemotherapy 51(5):227\u2013233","journal-title":"Chemotherapy"},{"issue":"5","key":"3392_CR3","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O'Grady NP, Bartlett JG, Carratala J, El Solh AA, Ewig S, Fey PD, File TM Jr, Restrepo MI, Roberts JA, Waterer GW, Cruse P, Knight SL, Brozek JL (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 63(5):e61\u2013e111","journal-title":"Clin Infect Dis"},{"issue":"12","key":"3392_CR4","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1093\/cid\/cis346","volume":"54","author":"BA Lipsky","year":"2012","unstructured":"Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, Deery HG, Embil JM, Joseph WS, Karchmer AW, Pinzur MS, Senneville E (2012) 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 54(12):e132\u2013e173","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"3392_CR5","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/511159","volume":"44","author":"LA Mandell","year":"2007","unstructured":"Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG (2007) Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27\u2013S72","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"3392_CR6","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1086\/499405","volume":"42","author":"MS Niederman","year":"2006","unstructured":"Niederman MS (2006) Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms. Clin Infect Dis 42(Suppl 2):S72\u2013S81","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3392_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/clinids\/11.3.361","volume":"11","author":"I Brook","year":"1989","unstructured":"Brook I (1989) Inoculum effect. Rev Infect Dis 11(3):361\u2013368","journal-title":"Rev Infect Dis"},{"issue":"9","key":"3392_CR8","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1086\/379021","volume":"37","author":"EC Nannini","year":"2003","unstructured":"Nannini EC, Singh KV, Murray BE (2003) Relapse of type a beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue. Clin Infect Dis 37(9):1194\u20131198","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3392_CR9","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1089\/mdr.2013.0229","volume":"20","author":"S Lee","year":"2014","unstructured":"Lee S, Kwon KT, Kim HI, Chang HH, Lee JM, Choe PG, Park WB, Kim NJ, Oh MD, Song do Y, Kim SW (2014) Clinical implications of cefazolin inoculum effect and beta-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia. Microbial drug resistance (Larchmont, NY) 20(6):568\u2013574","journal-title":"Microbial drug resistance (Larchmont, NY)"},{"issue":"8","key":"3392_CR10","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1128\/AAC.00317-09","volume":"53","author":"EC Nannini","year":"2009","unstructured":"Nannini EC, Stryjewski ME, Singh KV, Bourgogne A, Rude TH, Corey GR, Fowler VG Jr, Murray BE (2009) Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure. Antimicrob Agents Chemother 53(8):3437\u20133441","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3392_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10096-016-2799-1","volume":"36","author":"KH Song","year":"2017","unstructured":"Song KH, Jung SI, Lee S, Park S, Kiem SM, Lee SH, Kwak YG, Kim YK, Jang HC, Kim YS, Kim HI, Kim CJ, Park KH, Kim NJ, Oh MD, Kim HB (2017) Characteristics of cefazolin inoculum effect-positive methicillin-susceptible staphylococcus aureus infection in a multicentre bacteraemia cohort. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 36(2):285\u2013294","journal-title":"European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology"},{"key":"3392_CR12","doi-asserted-by":"crossref","unstructured":"Lee S, Song KH, Jung SI, Park WB, Lee SH, Kim YS, Kwak YG, Kim YK, Kiem SM, Kim HI, Kim ES, Park KH, Kim NJ, Jang HC, Kim HB (2017) Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis","DOI":"10.1093\/ofid\/ofw172.778"},{"issue":"8","key":"3392_CR13","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1128\/AAC.00533-15","volume":"59","author":"A Adler","year":"2015","unstructured":"Adler A, Ben-Dalak M, Chmelnitsky I, Carmeli Y (2015) Effect of resistance mechanisms on the inoculum effect of Carbapenem in Klebsiella pneumoniae isolates with borderline Carbapenem resistance. Antimicrob Agents Chemother 59(8):5014\u20135017","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"3392_CR14","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1128\/AAC.02190-12","volume":"57","author":"F Docobo-Perez","year":"2013","unstructured":"Docobo-Perez F, Lopez-Cerero L, Lopez-Rojas R, Egea P, Dominguez-Herrera J, Rodriguez-Bano J, Pascual A, Pachon J (2013) Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum beta-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model. Antimicrob Agents Chemother 57(5):2109\u20132113","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"3392_CR15","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ijantimicag.2014.01.030","volume":"43","author":"CI Kang","year":"2014","unstructured":"Kang CI, Cha MK, Kim SH, Wi YM, Chung DR, Peck KR, Lee NY, Song JH (2014) Extended-spectrum cephalosporins and the inoculum effect in tests with CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli: potential clinical implications of the revised CLSI interpretive criteria. Int J Antimicrob Agents 43(5):456\u2013459","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"3392_CR16","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/jac\/dkh462","volume":"54","author":"CI Kang","year":"2004","unstructured":"Kang CI, Pai H, Kim SH, Kim HB, Kim EC, Oh MD, Choe KW (2004) Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase. J Antimicrob Chemother 54(6):1130\u20131133","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"3392_CR17","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1128\/AAC.01325-09","volume":"54","author":"EC Nannini","year":"2010","unstructured":"Nannini EC, Stryjewski ME, Singh KV, Rude TH, Corey GR, Fowler VG Jr, Murray BE (2010) Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 54(5):2206\u20132208","journal-title":"Antimicrob Agents Chemother"},{"key":"3392_CR18","doi-asserted-by":"crossref","unstructured":"Saeki M, Shinagawa M, Yakuwa Y, Nirasawa S, Sato Y, Yanagihara N, Takahashi S (2017) Inoculum effect of high concentrations of methicillin-susceptible Staphylococcus aureus on the efficacy of cefazolin and other beta-lactams. J Infect Chemother Off J Jpn Soc Chemother","DOI":"10.1016\/j.jiac.2017.10.021"},{"issue":"12","key":"3392_CR19","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1128\/AAC.42.12.3163","volume":"42","author":"RK Voladri","year":"1998","unstructured":"Voladri RK, Kernodle DS (1998) Characterization of a chromosomal gene encoding type B beta-lactamase in phage group II isolates of Staphylococcus aureus. Antimicrob Agents Chemother 42(12):3163\u20133168","journal-title":"Antimicrob Agents Chemother"},{"key":"3392_CR20","unstructured":"National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically\u2014Seventh Edition: Approved Standard M07-A7. NCCLS, Wayne, PA, USA, 2008"},{"issue":"3","key":"3392_CR21","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1128\/AAC.01009-09","volume":"54","author":"K Bush","year":"2010","unstructured":"Bush K, Jacoby GA (2010) Updated functional classification of beta-lactamases. Antimicrob Agents Chemother 54(3):969\u2013976","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3392_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.idc.2016.02.007","volume":"30","author":"KM Papp-Wallace","year":"2016","unstructured":"Papp-Wallace KM, Bonomo RA (2016) New beta-lactamase inhibitors in the clinic. Infect Dis Clin N Am 30(2):441\u2013464","journal-title":"Infect Dis Clin N Am"},{"issue":"2","key":"3392_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10096-014-2241-5","volume":"34","author":"YP Chong","year":"2015","unstructured":"Chong YP, Park SJ, Kim ES, Bang KM, Kim MN, Kim SH, Lee SO, Choi SH, Jeong JY, Woo JH, Kim YS (2015) Prevalence of blaZ gene types and the cefazolin inoculum effect among methicillin-susceptible Staphylococcus aureus blood isolates and their association with multilocus sequence types and clinical outcome. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 34(2):349\u2013355","journal-title":"European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology"},{"issue":"8","key":"3392_CR24","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1128\/AAC.00052-12","volume":"56","author":"DJ Livorsi","year":"2012","unstructured":"Livorsi DJ, Crispell E, Satola SW, Burd EM, Jerris R, Wang YF, Farley MM (2012) Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 56(8):4474\u20134477","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"3392_CR25","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1093\/jac\/dkt254","volume":"68","author":"S Rincon","year":"2013","unstructured":"Rincon S, Reyes J, Carvajal LP, Rojas N, Cortes F, Panesso D, Guzman M, Zurita J, Adachi JA, Murray BE, Nannini EC, Arias CA (2013) Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from south American hospitals. J Antimicrob Chemother 68(12):2773\u20132778","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"3392_CR26","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1128\/AAC.34.3.420","volume":"34","author":"DS Kernodle","year":"1990","unstructured":"Kernodle DS, McGraw PA, Stratton CW, Kaiser AB (1990) Use of extracts versus whole-cell bacterial suspensions in the identification of Staphylococcus aureus beta-lactamase variants. Antimicrob Agents Chemother 34(3):420\u2013425","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"3392_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.diagmicrobio.2005.09.015","volume":"54","author":"JA Shuford","year":"2006","unstructured":"Shuford JA, Piper KE, Hein M, Trampuz A, Steckelberg JM, Patel R (2006) Lack of association of Staphylococcus aureus type a beta-lactamase with cefazolin combined with antimicrobial spacer placement prosthetic joint infection treatment failure. Diagn Microbiol Infect Dis 54(3):189\u2013192","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"3392_CR28","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.diagmicrobio.2015.07.011","volume":"83","author":"YM Wi","year":"2015","unstructured":"Wi YM, Park YK, Moon C, Ryu SY, Lee H, Ki HK, Cheong HS, Son JS, Lee JS, Kwon KT, Kim JM, Ha YE, Kang CI, Ko KS, Chung DR, Peck KR, Song JH (2015) The cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus blood isolates: their association with dysfunctional accessory gene regulator (agr). Diagn Microbiol Infect Dis 83(3):286\u2013291","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3392-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3392-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3392-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:32:59Z","timestamp":1662165179000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3392-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,30]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["3392"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3392-6","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,30]]},"assertion":[{"value":"13 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study entitled \u201cEstablishment of Network for Clinical Research of <i>Staphylococcus aureus<\/i> Infection\u201d had been approved by the IRB at each participating hospital, and the protocol used in this study using previously collected clinical information and corresponding isolates was approved by the IRB at Pusan National University Hospital (IRB No. E-2016032).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Nothing to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency declarations"}}]}}